.Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01X_OtherAntineoplasticAgents.L01XD03_MethylAminolevulinate.MethylAminolevulinate .Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01X_OtherAntineoplasticAgents.L01XD03_MethylAminolevulinate.MethylAminolevulinate| name: | MethylAminolevulinate |
| ATC code: | L01XD03 | route: | topical |
| n-compartments | 1 |
Methyl aminolevulinate is a photosensitizing agent used in photodynamic therapy, primarily for the treatment of non-melanoma skin cancers such as actinic keratosis, basal cell carcinoma, and Bowen's disease. It is administered topically and approved for clinical use in several countries.
Estimated pharmacokinetic parameters for topical administration in healthy adult humans; no direct published PK model parameters identified in literature.